Z-2817-2015 Class III Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-2817-2015 was initiated by Becton, Dickinson And Company, BD Biosciences on Aug 27, 2015 and is designated Class III. Reason for recall: CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC. The recall status is terminated (terminated Aug 9, 2016). Affected quantity: 128 units.

Recall details

Product Type
Devices
Report Date
Sep 30, 2015
Initiation Date
Aug 27, 2015
Termination Date
Aug 9, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
128 units

Product description

CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro diagnostic used in Hematology: The SK3 monoclonal antibody reacts with human CD4, a 59-kDa cell surface receptor expressed by a majority of thymocytes, a subpopulation of mature T helper cells, and at low levels on monocytes. CD4 is a receptor for the human immunodeficiency virus (HIV).

Reason for recall

CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC.

Distribution pattern

Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia.

Code information

Catalog Number 340133; lot # 5112711, Expiration date: 30 Nov 2016.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2817-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2817-2015. Report a data issue: hello@regdatalab.com.